Search Results - "Florez, Helena"

Refine Results
  1. 1

    Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis by Florez, Helena, Hernández-Rodríguez, José, Muxi, Africa, Carrasco, Josep Lluis, Prieto-González, Sergio, Cid, Maria C, Espinosa, Gerard, Gómez-Puerta, Jose A, Monegal, Ana, Guañabens, Núria, Peris, Pilar

    Published in Rheumatology (Oxford, England) (01-07-2020)
    “…Abstract Objective To analyse the clinical utility of trabecular bone score (TBS) evaluation for fracture risk assessment in glucocorticoid (GC)-treated…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Effect of gender on the evolution of pain and quality of life after treatment of symptomatic vertebral fragility fractures by Peris, Pilar, Blasco, Jordi, Monegal, Ana, Florez, Helena, Guañabens, Núria, Carrasco, Josep Lluis

    Published in Osteoporosis international (01-03-2024)
    “…Summary The evolution of pain and quality of life after a symptomatic vertebral fracture differs according to patient gender, with a worse evolution in women…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Acute generalized exanthematous pustulosis and polyarthritis associated with a novel CARD14 mutation by Podlipnik, Sebastian, Castellanos‐Moreira, Raul, Florez‐Enrich, Helena, Arostegui, Juan Ignacio, Mascaró, José Manuel

    Published in Australasian journal of dermatology (01-02-2018)
    “…Acute generalised exanthematous pustulosis (AGEP) is a rare toxicoderma characterised by an acute onset rash, with many sterile pustules on the surface, high…”
    Get full text
    Journal Article
  9. 9

    Spontaneous vertebral fractures after denosumab discontinuation: A case collection and review of the literature by Florez, Helena, Ramírez, Julio, Monegal, Ana, Guañabens, Núria, Peris, Pilar

    Published in Seminars in arthritis and rheumatism (01-10-2019)
    “…•Denosumab discontinuation can be associated with the development of multiple vertebral fractures.•Previous treatment with bisphosphonates does not seem to…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Fibrous dysplasia. Clinical review and therapeutic management by Florez, Helena, Peris, Pilar, Guañabens, Núria

    Published in Medicina clinica (16-12-2016)
    “…Fibrous dysplasia is a skeletal disorder that is associated with a wide spectrum of clinical manifestations, including localized asymptomatic forms and…”
    Get more information
    Journal Article
  13. 13

    Tartrate-resistant acid phosphatase 5b, but not periostin, is useful for assessing Paget's disease of bone by Guañabens, Núria, Filella, Xavier, Florez, Helena, Ruiz-Gaspá, Silvia, Conesa, Arantxa, Peris, Pilar, Monegal, Ana, Torres, Ferran

    Published in Bone (New York, N.Y.) (01-07-2019)
    “…Periostin is a matricellular protein with a preferential location in cortical bone and periosteal tissue, and tartrate-resistant acid phosphatase 5b (TRAP5b)…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Clinical significance of increased serum levels of FGF-23 in fibrous dysplasia by Florez, Helena, Mandelikova, Stanislava, Filella, Xavier, Monegal, Ana, Guañabens, Núria, Peris, Pilar

    Published in Medicina clínica (English ed.) (23-07-2018)
    “…Fibrous dysplasia (FD) can be associated with the development of hypophosphatemic osteomalacia, caused by the production of FGF-23 by dysplastic bone tissue…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Fibrous dysplasia. Clinical review and therapeutic management by Florez, Helena, Peris, Pilar, Guañabens, Núria

    Published in Medicina clínica (English ed.) (16-12-2016)
    “…Fibrous dysplasia is a skeletal disorder that is associated with a wide spectrum of clinical manifestations, including localized asymptomatic forms and…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20